Brief: Ovid Therapeutics Reports Second Quarter 2023 Financial Results
04/08/2023 13:08
Aug 4 (Reuters) - Ovid Therapeutics Inc OVID.O :
* OVID THERAPEUTICS REPORTS SECOND QUARTER 2023 FINANCIAL
RESULTS
AND CORPORATE UPDATES
* OVID THERAPEUTICS INC Q2 LOSS PER SHARE $0.18
* OVID THERAPEUTICS INC Q2 EARNINGS PER SHARE VIEW $-0.20 --
REFINITIV IBES DATA
* OVID THERAPEUTICS INC - CASH RUNWAY SHOULD FUND OPERATIONS
INTO
2025 AND WILL SEEK TO EXTEND RUNWAY BEYOND THIS PERIOD
Source text for Eikon: ID:nGNX6RWVqV
Further company coverage: OVID.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ovid Therapeutics
See all newsOvid Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Ovid Therapeutics Q2 revenue beats estimates
Brief: Ovid Therapeutics Q2 EPS USD -0.08
Ovid Therapeutics Inc. expected to post a loss of 11 cents a share - Earnings Preview
Brief: Ovid Therapeutics Appoints Leading Physician-Scientist And Biotech Innovator Anna Greka, M.D., Ph.D., To Board Of Directors